Mesima (Phellinus linteus)
What Is Mesima?
Mesima is the common name for Phellinus linteus, a fungus of the Hymenochaetaceae family, native to the mulberry and hardwood forests of East Asia. The material in circulation is fruiting body — the fruiting body of the plant. The common name Mesima and the botanical name Phellinus linteus refer to the same material, and labels may use either — a detail that matters when related species in the same genus are not interchangeable. Its character is described as bitter-earthy, woody-mushroom, which is often how the raw material is checked for quality.
Mesima entered the reference literature through use rather than through chemistry. Older sources are concerned with where it grows, when it is gathered and how it is prepared, questions that still shape the material on sale today. Beyond its practical use it carries cultural associations — korean 'sang-hwang' — wild mulberry forest gift, harvested with reverence.
Today most searches for Mesima come from people reading about antiviral, immune boost and energy, or checking how it sits alongside a medication they already take. The use most often documented in the literature is immunostimulant proteoglycans (Mesima Mushroom Extract), followed by adjunct in oncology — small RCTs in breast and colorectal cancer.
How Does Mesima Work?
Mesima is not a single active substance. Its chemistry is a mixture, and the fractions that researchers isolate most often are Polysaccharides. Polysaccharides is the fraction most often standardised in extracts, associated in the literature with immunostimulant carbohydrate polymers.
Traditional practice described Mesima in terms of taste, warmth and preparation rather than molecules — a working vocabulary that predicted which extractions were worth making long before any compound was isolated.
The research base is developing: there are human trials, though sample sizes and designs vary, and this profile cites 1 source. Reported findings centre on kim et al. Where research exists, it examines immunostimulant proteoglycans (Mesima Mushroom Extract), adjunct in oncology — small RCTs in breast and colorectal cancer and antiviral and antifibrotic activity. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into water — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
The reason Mesima is treated as its own entry rather than a substitute for a related plant is proportion: related species share several of these compound classes, but not in the same ratio or concentration.
Because these constituents are processed by the same pathways that handle many medicines, Mesima is documented as interacting with anticoagulants and chemotherapy. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Mesima can differ substantially; this is why reference entries specify fruiting body and, where they exist, standardisation markers.